ilyas sahin, MD

@ilyassahinmd

Assistant Professor @HarvardMed | GI Medical Oncologist @MassGeneralNews | Liver & GI Cancers | Clinical Trials

following
followers

Science

KRAS G12D drug reportedly shrinks tumors in phase 1 pancreatic and lung cancer study

A post describing a Nature Medicine study reports tumor shrinkage in about 1 in 3 heavily pretreated patients taking GFH375/VS-7375, and grade 3 or higher treatment-related side effects in about a third.

1 Source, 49d ago, first seen 49d ago

Featured in

KRAS G12D drug reportedly shrinks tumors in phase 1 pancreatic and lung cancer study

Featured in

KRAS G12D drug reportedly shrinks tumors in phase 1 pancreatic and lung cancer study